Reaction
Carbohydrate Antigen 19-9 Increased reporting signals
As of the last recalculation, Carbohydrate Antigen 19-9 Increased appears in 512 FAERS reports alongside 17 co-occurring drug terms. The strongest observed disproportionality signal is IRINOTECAN HYDROCHLORIDE (PRR 55.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Irinotecan Hydrochloride | 17 | 55.6 | 55.6 |
| Panitumumab | 20 | 54.0 | 54.0 |
| Regorafenib | 13 | 46.7 | 46.7 |
| Ado-Trastuzumab Emtansine | 7 | 34.2 | 34.2 |
| Gemcitabine Hydrochloride | 37 | 30.5 | 30.5 |
| Erlotinib | 6 | 25.5 | 25.5 |
| Encorafenib | 6 | 24.9 | 24.9 |
| Fluorouracil Cream, 0.5% | 42 | 24.3 | 24.3 |
| Fluorouracil | 42 | 24.0 | 24.0 |
| Gemcitabine | 22 | 23.7 | 23.7 |
| Oxaliplatin | 36 | 21.1 | 21.2 |
| Erlotinib Hydrochloride | 6 | 19.7 | 19.7 |
| Olaparib | 9 | 17.8 | 17.8 |
| Cetuximab | 11 | 14.6 | 14.6 |
| Durvalumab | 6 | 12.1 | 12.1 |
| Trifluridine And Tipiracil | 3 | 11.4 | 11.4 |
| Benralizumab | 5 | 10.2 | 10.3 |